Previous 10 | Next 10 |
Preamble: COVID-19 might destroy huge swaths of the consumer economy as it runs its course (or it might not) but rather than predict epidemiological curves, we are better served finding opportunities in parts of the economy that have no real exposure to COVID. The one area that stands out...
AMAG Pharmaceuticals, Inc. (AMAG) Q1 2020 Results Earnings Conference Call May 11, 2020, 08:00 AM ET Company Participants Linda Lennox - VP, IR Scott Myers - President and CEO Ted Myles - COO and CFO Tony Casciano - Chief Commercial Officer Conference Call Participants A...
Gainers: Cellect Biotechnology (NASDAQ: APOP ) +77% . More news on: Cellect Biotechnology Ltd., MyoKardia, Inc., Remark Holdings, Inc., Stocks on the move, , Read more ...
AMAG Pharmaceuticals (NASDAQ: AMAG ): Q1 GAAP EPS of -$0.72 misses by $0.23 . More news on: AMAG Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
Feraheme ® (ferumoxytol injection) posts strong first quarter results Company implements a workforce reduction of approximately 30 percent or 140 positions, as part of a planned decrease in operating expenses Conference call scheduled for 8:00 a.m. ET today WALTHAM, Mas...
Last year, the U.S. Food and Drug Administration (FDA) approved Vyleesi, the second-ever treatment for premenopausal women who have low sexual desire (known as generalized hypoactive sexual desire disorder). Although investors' expectations were high, efforts by AMAG Pharmaceuticals (NAS...
Scott Myers has been appointed president, CEO, and board member at AMAG Pharmaceuticals (NASDAQ: AMAG ). Myers most recently was chairman and CEO and Rainier Therapeutics. More news on: AMAG Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move, Read more ...
WALTHAM, Mass., April 28, 2020 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that its Board of Directors has appointed Scott Myers as AMAG’s President and Chief Executive Officer, and member of the Board, effective immediately. Mr. Myers succeeds Wil...
WALTHAM, Mass., April 27, 2020 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that its first quarter 2020 financial results will be released on Monday, May 11, 2020 before the U.S. financial markets open. Management will host a conference call and webcast at 8...
AMAG Pharmaceuticals ( AMAG +0.1% ) all products currently remain available to patients. More news on: AMAG Pharmaceuticals, Inc., Healthcare stocks news, Read more ...
News, Short Squeeze, Breakout and More Instantly...
AMAG Pharmaceuticals Inc. Company Name:
AMAG Stock Symbol:
NASDAQ Market:
AMAG Pharmaceuticals Inc. Website:
WALTHAM, Mass., Dec. 14, 2020 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. has submitted its response to the FDA’s Notice of Opportunity for a Hearing (“NOOH”) regarding the Agency’s proposal to withdraw approval for Makena—also referred to as 17-OHP...
MGIC Investment & Halozyme Therapeutics Set to Join S&P MidCap 400; First Bancorp, The Geo Group & Mednax to Join S&P SmallCap 600 MGIC Investment & Halozyme Therapeutics Set to Join S&P MidCap 400; First Bancorp, The Geo Group & Mednax to Join S&...
WALTHAM, Mass., Oct. 14, 2020 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) announced today that it has formally requested a public hearing in response to the U.S. Food and Drug Administration’s (FDA) proposal to withdraw its approval of Makena ® , the only F...